Mushroom toxicity: Difference between revisions

(Gyromitra mushroom pic)
(Cortinarius mushroom pic)
Line 115: Line 115:


===''Crotinarius'' mushrooms===
===''Crotinarius'' mushrooms===
[[File:Cortinarius_mushroom.jpg|thumb|Cortinarius mushroom]]
* contain toxin Orellanine
* contain toxin Orellanine



Revision as of 22:40, 17 April 2015

Background

Major Categories

  1. Early-Onset Poisoning
    1. Toxicity begins within 2hr of ingestion; clinical course is usually benign
  2. Late-Onset Poisoning
    1. Toxicity begins 6hr after ingestion; clinical course is often serious/ possibly fatal
Mushroom Toxin Pathologic Effect
Amatoxin Hepatotoxicity
Coprine Disulfiram-like
Gyromitrin Seizures
Ibotenic Acid Anticholinergic
Muscarine Cholinergic
Orellanin Naphrotoxicity
Psilocybin Hallucinations

Differential Diagnosis

Causes of acute hepatitis

Early-Onset Poisoning

  • Comprises majority of mushroom-induced intoxications

Clinical Features

  • Depends on the type of mushroom ingested
  • GI
    • Nausea/vomiting/diarrhea
    • Resolves within 24hr
  • CNS
    • Euphoria, hallucinations
    • Lasts 4-6hr
  • Muscarinic
    • SLUDGE symptoms
    • Diaphoresis, muscle fasciculations, miosis, bradycardia, bronchorrhea
    • Resolves in 4-12hr
  • Disulfiram-like effect
    • Usually when drinking alcohol
    • Flushing, tachycardia, diaphoresis, hypotension

Treatment

  • GI predominant symptoms:
    • Activated charcoal 0.5-1gm/kg
    • Do not give antidiarrheal meds
  • CNS predominant symptoms:
    • Place in dark, quiet room
    • Benzos may be given to pts who are agitated
  • Muscarinic predominant symptoms:
    • Consider atropine for severe symptoms; 0.5-1mg IV for adults; 0.01mg/kg IV for peds

Disposition

  • Discharge once symptoms have subsided

Delayed-Onset Poisoning

  • Amanita species causes 95% of deaths
    • Toxin inhibits formation of mRNA and is heat stable

Amanita phalloides

Amanita phalloides aka death cap

Clinical Findings

  • Stage 1 (GI)
    • Occurs 6-24hr after ingestion and lasts 12-24hr
    • The later the onset of symptoms the better the outcome
    • GI predominant symptoms:
      • Abd pain, vomiting and diarrhea (which may become bloody)
  • Stage 2 (convalescent)
    • Occurs 48hr after ingestion and lasts 12-24hr
    • Symptoms subside and pt appears better
    • Liver deteriorates silently and precipitously (LFTs begin to rise)
  • Stage 3 (failure)
    • Occurs 2-4d after ingestion
    • Fulminant liver failure
      • Hyperbilirubinemia, coagulopathy, hepatic encephalopathy, hepatorenal syndrome

Treatment

  • Immediate therapy
    • Activated charcoal
      • Some advocate repeated doses during the first 24hr
        • Amatoxin undergoes enterohepatic circulation
    • Penicillin
      • High doses 1 mil units/kg/d effective in animal studies (inhibits amatoxin uptake)
    • Silibinin (milk thistle)
      • Free radical scavenger used successfully in Europe; 25-50mg/kg/d
  • Ongoing therapy
    • Glucose monitoring
      • Hypoglycemia is one of the most common causes of death in early mushroom toxicity
    • Liver/renal failure monitoring
      • Serial LFTs, chem, coags
    • Prepare for liver transplant
      • Progressive coagulopathy, encephalopathy, renal failure are indications for transplant

Disposition

  • Admit all pts suspected of ingesting amatoxin containing mushrooms for at least 48hr

Gyromitra mushrooms

Gyromitra mushrooms
  • also known as "brain fungi"
  • inhibits formation of Vitamin B6 and BAGA

Clinical findings

  • GI upset, fatigue, muscle cramps
  • Can present with refractory seizures

Treatment

  • Supportive care
  • High dose pyridoxine for refractory seizures (5g IV initially)

Crotinarius mushrooms

Cortinarius mushroom
  • contain toxin Orellanine

Clinical findings

  • Headache, chills, malaise, nausea and vomiting over days
  • Can see delayed renal failure 1-3 weeks after exposure

Treatment

  • Supportive
  • If renal failure from mushroom exposure, recovery can take several weeks. May need temporary hemodialysis.

Source

Tintinalli Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose

  1. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.